[
  {
    "rationale": "None of the listed patient concerns were captured; note covers unrelated issues.",
    "satisfaction": 0,
    "score": 0.0
  },
  {
    "rationale": "No documentation of glipizide missed-dose counseling.",
    "satisfaction": 0,
    "score": 0.0
  },
  {
    "rationale": "No semaglutide injection or nausea guidance recorded.",
    "satisfaction": 0,
    "score": 0.0
  },
  {
    "rationale": "No cost-mitigation strategies documented.",
    "satisfaction": 0,
    "score": 0.0
  },
  {
    "rationale": "Demographics/active problems/med list not copied; entirely different patient described.",
    "satisfaction": 0,
    "score": 0.0
  },
  {
    "rationale": "Introduces pregnancy, Crohn\u2019s, adalimumab\u2014information not in source scenario.",
    "satisfaction": 0,
    "score": -15.0
  },
  {
    "rationale": "Nurse enrollment and pharmacist sticker tasks omitted.",
    "satisfaction": 0,
    "score": -10.0
  },
  {
    "rationale": "Note misses >90 % of relevant details and is disorganized relative to scenario.",
    "satisfaction": 0,
    "score": 0.0
  },
  {
    "rationale": "Semaglutide and glipizide not mentioned; substituted unrelated meds\u2014incorrect data.",
    "satisfaction": 0,
    "score": -5.0
  }
]